Seekingalpha.com

Biogen Stock: Alzheimer’s Drug, Hope Is Not Enough (NASDAQ

Only 16 of the 253 drugs approved under the accelerated program have been withdrawn. FDA approval was the key to a potential bonanza for Biogen. The point is …

Actived: 4 days ago

URL: seekingalpha.com


Why Are The Costs Of Prescription Medications Rising

(3 days ago) Developing new drugs is a long and expensive process that usually takes about 12 years, from preclinical testing to final approval. Only between 10 and …

Category:  Health Go Now


TFF Pharmaceuticals: Innovative Drug Reformulation

(1 days ago) Source. There are two clinical stage drugs here. TFF Vori, which is an inhalable version of voriconazole for the treatment of invasive pulmonary aspergillosis (IPA), …

Category:  Health Go Now


NASH Drugs: A Comprehensive Review Of Current Clinical

(9 days ago) NASH has no FDA-approved therapy and could represent a $35 billion market by 2025, prompting many biotechs to race for the approval of the first NASH-targeted drugs.

Category:  Health Go Now


Moderna Aims To Revolutionize Modern Medicine With A New

(5 days ago) moderna had the largest IPO in biotech history. mRNA drugs may bring about a paradigm-shift in modern medicine. Stock market Insights & financial analysis, including free earnings call …

Category:  Health Go Now


The First Deuterated Drug Arrives (NYSE:TEVA) Seeking Alpha

(Just Now) For drugs, the key is that many of them are metabolized and destroyed when they hit they liver, and this is often done through breaking a C-H bond. …

Category:  Health Go Now


Novartis: Drug Pipeline And New Drug Applications (NYSE

(9 days ago) Novartis plans to file 9 New Drug Applications (NDA) for existing drugs and new molecular entities in 2013. We estimate that the new drugs will generate aggregate revenues of …

Category:  Health Go Now


ADHD Check-Up: Which Future Medications Have The Greatest

(8 days ago) Supernus is a solid company that is worth holding for many reasons, but the potential of this pair of drugs (and particularly SPN-812) seems to be largely ignored by a market that is focused on

Category:  Health Go Now


Are Expensive Biotech Drugs Bad For Business

(5 days ago) Summary. A huge number of expensive drugs in the pipeline. Gilead powers on with $50,000 - $80,000 Hepatitis C treatments. Dendreon files for bankruptcy when …

Category:  Health Go Now


ViroPharma: A Tale of Two Drugs (NASDAQ:SHPG) Seeking Alpha

(Just Now) ViroPharma (VPHM) is a relatively small biotech with two drugs on the market. Stock market Insights & financial analysis, including free earnings call transcripts, investment ideas and ETF & …

Category:  Health Go Now


Eli Lilly (LLY) Stock: A Strong Buying

(9 days ago) The product portfolio consists of nine blockbuster drugs, each generating more than $1 billion in revenues and three more on the horizon. Undervalued Dividend Challenger offers a …

Category:  Health Go Now


Gilead Sciences' Move Into Cancer Drugs (NASDAQ:GILD

(9 days ago) Little noticed Gilead Sciences (NASDAQ:GILD), the world's largest maker of HIV drugs, has spent $1.2 billion in the past two years to buy up developers of blood cancer drugs.Treatment for

Category:  Cancer Go Now


Roche (RHHBY): One Of The Best Pharma Stocks You Can Buy

(8 days ago) Roche is a giant among pharmaceutical companies and carries a stellar balance sheet. Newer drugs, including those in oncology, now represent over half of Roche's pharmaceutical sales.

Category:  Pharmaceutical Go Now


An Investor's Look At The New Drugs Of 2018 And Their

(4 days ago) Summary. In 2018, the FDA approved 59 new drugs, up from the 46 in 2017, setting a new record. Among the approvals, 19 drugs have novel mechanisms of action, 14 breakthrough therapies, 34 orphan

Category:  Health Go Now


Merck COVID-19 pill among antivirals WHO-led program plans

(1 days ago) The program plans to enable poorer nations to access about 1B tests and purchase drugs to treat up to 120M patients globally out of 200M new cases estimated for the next 12 months.

Category:  Health Go Now


3 Pharmaceutical Companies Awaiting FDA Approval, Part II

(7 days ago) Of the three drugs discussed, Raptor is the only one which might face some trouble given the gastrointestinal side effects associated with it, especially …

Category:  Health Go Now


CBO: Drug pricing bill could stymie pharma, biotech R&D

(8 days ago) A CBO paper issued in 2019 found that the proposed legislation, H.R. 3, would reduce global revenue for new drugs by 19 percent, leading to about 8 fewer drugs introduced to …

Category:  Health Go Now


EPO Pills: A Challenge For Amgen And Johnson & Johnson

(6 days ago) EPO pills are a new technology currently in development. Their mechanism of action is entirely different from the one used by Amgen and Johnson & …

Category:  Health Go Now

Top Categories

Popular Searched

 › Cvs specialty pharmacy fax form

 › Medicare benefits by zip code

 › Black women and mental health pdf

 › What is behavioral health

 › Medicare tier 1 drugs list

 › Myuhcmedicare health & wellness products catalog

 › Free medical scribe courses

 › Shoppers drug mart cologne set

 › Preferred pharmacy for aarp

 › Ohio boards of pharmacy

 › Jackson internal medicine residency

 › Stl behavioral medicine institute

 › Columbia memorial hospital lab valatie

 › West allis care center milwaukee

 › Lynparza limited distribution pharmacy

Recently Searched

 › Is medicare and medicaid the same thing

 › Duke health roxboro rd

 › Ssa gov medicare only application

 › Medicare 5 star drug plans

 › Atlantic medical insurance provider portal

 › Tricare east provider credentialing status

 › Nc emt basic drug cards

 › Tufts school of medicine gpa

 › Medicare number with t

 › Medicare covered drugs for ed

 › How to get medicare number from ssa

 › Mnemonics to remember drugs

 › Ccf medical records release

 › Cleveland clinic medical records release of information

 › Pa schedule of drugs